✦ LIBER ✦

CPT-11 for Bile-Duct and Gallbladder Carcinoma: A Phase II North Central Cancer Treatment Group (NCCTG) Study

✍ Scribed by Alberts, Steven R. ;Fishkin, Paul A. ;Burgart, Lawrence J. ;Cera, Peter J. ;Mahoney, Michelle R. ;Morton, Roscoe F. ;Johnson, Patricia A. ;Nair, Suresh ;Goldberg, Richard M.

Book ID: 111638877
Publisher: Springer
Year: 2002
Tongue: English
Weight: 138 KB
Volume: 32
Category: Article
ISSN: 1537-3649
DOI: 10.1385/ijgc:32:2-3:107

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Pemetrexed and Gemcitabine for Biliary T

Pemetrexed and Gemcitabine for Biliary Tract and Gallbladder Carcinomas: a North Central Cancer Treatment Group (NCCTG) Phase I and II Trial, N9943

✍ Steven R. Alberts; Jonathan R. Sande; Nathan R. Foster; Fernando J. Quevedo; Rob 📂 Article 📅 2007 🏛 Springer US 🌐 English ⚖ 254 KB

Gemcitabine, 5-fluorouracil, and leucovo

Gemcitabine, 5-fluorouracil, and leucovorin in advanced biliary tract and gallbladder carcinoma : A North Central Cancer Treatment Group Phase II Trial

✍ Steven R. Alberts; Hani Al-Khatib; Michelle R. Mahoney; Lawerence Burgart; Peter 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 97 KB 👁 2 views

Use of KW-2189, a DNA Minor Groove-Bindi

Use of KW-2189, a DNA Minor Groove-Binding Agent, in Patients with Hepatocellular Carcinoma: A North Central Cancer Treatment Group (NCCTG) Phase II Clinical Trial

✍ Steven R. Alberts; Vera J. Suman; Henry C. Pitot; John K. Camoriano; Joseph Rubi 📂 Article 📅 2007 🏛 Springer US 🌐 English ⚖ 84 KB

Hepatic Arterial Infusion and Systemic C

Hepatic Arterial Infusion and Systemic Chemotherapy After Multiple Metastasectomy in Patients With Colorectal Carcinoma Metastatic to the Liver: A North Central Cancer Treatment Group (NCCTG) Phase II Study, 92-46-52

✍ John S. Bolton; Michael J. O'Connell; Michelle R. Mahoney; Gist H. Farr Jr; Tom 📂 Article 📅 2012 🏛 CIG Media Group, LP. 🌐 English ⚖ 344 KB

259 Patterns of failure after liver rese

259 Patterns of failure after liver resectionin patients receiving FOLFOX4 for metastatic colorectal cancer (MCRC) limited to the liver: a North Central Cancer Treatment Group (NCCTG) phase II study

✍ S. Alberts; J. Donohue; M. Mahoney; W. Horvath; W. Sternfield; S. Dakhil; R. Lev 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 169 KB

North Central Cancer Treatment Group (NC

North Central Cancer Treatment Group (NCCTG) N0537: Phase II Trial of VEGF-Trap in Patients With Metastatic Breast Cancer Previously Treated With an Anthracycline and/or a Taxane

✍ Kostandinos Sideras; Amylou C. Dueck; Timothy J. Hobday; Kendrith M. Rowland Jr. 📂 Article 📅 2012 🏛 CIG Media Group, LP. 🌐 English ⚖ 280 KB